![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 17")
Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
Comments Off on Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
March 31, 2026
✦ New CED Clinical Relevance #78Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdPolicyInsurance…
Did Carrier have to Cough up Cash for THC Edibles of Worker with Chronic Pain?
Comments Off on Did Carrier have to Cough up Cash for THC Edibles of Worker with Chronic Pain?
March 26, 2026
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Workers CompensationChronic…
5 Transformative Effects of Cannabis Rescheduling: Medical Insight
Comments Off on 5 Transformative Effects of Cannabis Rescheduling: Medical Insight
May 2, 2024
In a recent landmark announcement on Cannabis Rescheduling, President Biden expressed his administration's commitment to support the rescheduling of cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act. This shift could…